Dr. Adam M. SELAMNIA (Ph.D. / MBA)
Senior Scientific Advisor in Esch-sur-Alzette, Luxembourg
After his PhD in Physiology of Human Nutrition (Univ. Paris 7, France) in 1997, Dr. Adam M. SELAMNIA started a postdoctoral fellowship for 18 months in basic oncology at Penn State University College of Medicine (USA). Back in France, he earned an MBA in Marketing BtoB at Paris-La Défense and started to work for a Business Consultant firm in Biotech.
In 2001, he co-founded IMEDIAL (France) where he has developed an expertise in pharmaceutical promotion activities.
In 2008, he founded DCIS (Decisions and Innovation Consulting and Health) located in Paris (France), and Co-founded SANOIA.COM a PHR solution.
In 2010, he was the Business Development Manager of ATLANGRAM (France) a Pre-Clinical CRO in Therapeutic Animal Models for Infectious diseases.
In 2012, he decided to devote himself entirely to Health 2.0, to Training & Lectures for the Life Sciences.
In 2016, he continued to go for the Extra-Mile by co-founding WELLELSE, a luxembourg-based company dedicated to well-being for individuals and organisations using ICT tools.
In 2017, he joined a Think-and-Do Tank, Le Cercle du Leadership as General Secretary to help leaders and organisations nurture innovation in Leadership and Management.
In 2018, he joined the Not-for-profit association dedicated to sustainable innovation Association Ecosystème Innovation Responsable to head the management of the largest event in East of France on the subject focused this year on Artificial and Collective Intelligence.
In 2019, he'll keep going the extra-mile and bridging gaps between diverse actors of innovation, science and technology.